Paraguayan health authorities Thursday confirmed the first case of monkeypox in the South American country. It was an adult male patient of Paraguayan nationality with a travel history, it was reported. Meanwhile, 17 suspected cases were ruled out.
Bolivian health authorities Wednesday announced that an 11-year-old girl in the department of Cochabamba was among the 49 confirmed cases in the country of monkeypox, a malady that usually affects male adults.
Uruguayan authorities have announced they would no longer require affidavits from incoming travelers attesting to their health covid-19-wise, in addition to granting tax exemptions on hotel and restaurant bills to foreign visitors, effective as of next month.
Cuba and Mexico have joined the list of countries such as Brazil, Peru, and Spain, where people with monkeypox have died, it was reported Tuesday. Worldwide, there have been 41,664 cases and 12 deaths.
Uruguayan health authorities have confirmed a third monkeypox infection had been detected in the country after 38 suspected cases were ruled out.
After a long season in Antarctica, Falkland Islands' flagged exploration ship RRS Sir David Attenborough has docked in Belfast for the first time, to pick up new crew members ahead of carrying out further scientific studies around the UK coastline. The state of the art vessel is owned by the Natural Environment Research Council and operated by the British Antarctic Survey.
Brazil's Health Ministry Monday launched an awareness campaign on monkeypox, to inform the population about transmission, contagion, and symptoms of the malady.
Cuban authorities have confirmed during the weekend the first case of monkeypox in the country. It was a 38-year-old Italian tourist who was reported to be in serious condition, according to Granma.
Paraguayan health authorities have expressed their concern over a slowdown in vaccination against COVID-19, with very few booster doses applied.
Brazil's National Health Surveillance Agency (Anvisa) has received a request for the emergency use of Pfizer's newest vaccine against COVID-19 which would be active against both the original and the Ômicron strain, subvariant BA.1.